CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.

Quotes for CS MEDICA A/S

Right Now

+/-
-0.24
%
-2,64%
Latest
8.86
High
9.38
Low
8.84
Volume
9 800
Turnover (DKK)
87 979
Market Value (MDKK)
109,2
Time (Latest trade)
2022-11-30 12:39

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Jørgen Flemming Ladefoged

Board

  • Alexandre Fevre
  • Anders Permin
  • Gitte Lund Henriksen
  • Stein Løkstad

Largest Owners

Name Capital % Votes % Date
Lone Henriksen 37,06 37,06 2022-08-16
Gitte Henriksen 36,72 36,72 2022-08-18
Finn-Ove Henriksen and Nina Henriksen 3,34 3,34 2022-06-30
Diaz Capital Invest AB 3,23 3,23 2022-08-24
Ylber Rexhepi 2,32 2,32 2022-06-30
Tonoy Sayeed 1,46 1,46 2022-06-30
Michael Kaa Andersen 1,18 1,18 2022-06-30
Tobias Ryde 1,10 1,10 2022-06-30
Kent Eklund 1,03 1,03 2022-06-30
Taulant Bara 1,03 1,03 2022-06-30
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-02-09 Årsstämma 2022

  • 2023-02-17 Delårsrapport 2023-Q1

  • 2023-05-17 Delårsrapport 2023-Q2

  • 2023-07-18 Delårsrapport 2023-Q3

  • 2023-11-17 Bokslutskommuniké 2023

  • 2023-12-14 Årsstämma 2023